[Federal Register Volume 69, Number 120 (Wednesday, June 23, 2004)]
[Notices]
[Pages 35035-35039]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-14174]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Demonstration Projects for Implementation of Rapid HIV Testing in 
Historically Black Colleges and Universities and Alternative Venues and 
Populations

    Announcement Type: New.
    Funding Opportunity Number: 04158.
    Catalog of Federal Domestic Assistance Number: 93.943.

DATES: Application Deadline: July 23, 2004.
SUMMARY: The purpose of this project is to demonstrate new models for 
diagnosing HIV infection, a priority strategy in the context of the 
Advancing HIV Prevention Initiative (AHP). AHP is aimed at reducing the 
number of new infections caused by Human Immunodeficiency Virus (HIV) 
each year in the United States by emphasizing greater access to HIV 
testing and provision of prevention and care services for persons 
infected with HIV. Demonstration projects will be funded to show the 
feasibility, and demonstrate best methods of, integrating routine HIV 
testing programs (including rapid testing), in a variety of venues.
    Current HIV screening programs rely on individual, provider-
administered assessments of risks for HIV infection, and do not 
identify risks which would indicate HIV testing for all HIV-infected 
persons. The alternative to individual risk assessment is the offering 
of HIV testing on a routine basis. Where routine offering of HIV 
testing has been utilized in areas with high HIV prevalence, the rate 
of HIV positive tests (two to seven percent in hospitals and emergency 
rooms) is similar to or exceeds that observed nationally in publicly 
funded HIV counseling and testing sites (two percent) and Sexually 
Transmitted Disease (STD) clinics (1.5 percent). HIV prevalence among 
persons tested in outreach settings is also consistently higher than 
among those tested at traditional testing clinics.
    Historically, many persons tested in outreach settings never 
receive their test results. Because results of rapid HIV tests are 
available within 30 minutes, rapid HIV testing offered routinely in a 
variety of clinical settings and outreach efforts in nonclinical 
settings in high-risk communities has the potential to both reach 
persons at high-risk for HIV infection and to ensure that they will 
receive their test results.
    The first part of this announcement describes a funding opportunity 
for demonstration projects to provide rapid HIV testing at Historically 
Black Colleges and Universities (HBCUs). Recent presidential 
proclamations support the development of research aimed at, and 
resources earmarked for HBCUs. There are between 102 and 118 HBCUs in 
the US, mostly in the South. The collective African-American student 
body of these schools exceeds 150,000 with an approximate age range of 
18-35.
    New and innovative HIV prevention programs that focus on young 
African American college students are needed; this is made clear by the 
epidemiology of HIV in the United States, and by a recently identified 
cluster of HIV infections among young African American male college 
students attending HBCUs in the South. Black males (and to a lesser 
extent Black females), ages 18-44 are the racial/ethnic group most 
disproportionately affected by HIV in the entire United States. A 
recent cluster of HIV infections among black male college students in 
North Carolina underscored the urgency of focusing attention and 
prevention efforts on young adults who may not have been previously or 
adequately served by HIV prevention programs.
    CDC will use findings from these demonstration projects to design 
and implement HIV/AIDS prevention messages and activities in diverse 
settings, and serving diverse populations.
    The second part of this announcement includes new strategies to 
identify HIV positive persons in order to provide assistance for 
linkage to treatment, care and prevention services. Because many newly 
diagnosed HIV positive persons have received care in medical settings 
in the year preceding their diagnosis without being offered HIV 
testing, diverse medical settings are the focus of the second part of 
this announcement. CDC will support primary care clinics, or 
alternative medicine clinics (homeopathic, naturopathic or 
chiropractic), that service high risk populations and/or communities, 
to develop demonstration projects to offer HIV testing to their 
clients. The Primary Care clinics will include, but will not to be 
limited to: public or private health centers; ambulatory clinics; WIC 
clinics; managed care organizations; or other primary care facilities, 
either affiliated with a university, health department, or community 
based organization.
    The third part of the announcement focuses on Native Americans, 
migrant farm workers and pre-or post-operative transgendered persons. 
These are communities that are disproportionately affected by HIV or 
are at increased risk for emerging HIV epidemics because of high levels 
of risk behaviors associated with HIV transmission. We will fund health 
departments and community based organizations to create projects to 
demonstrate new outreach models for rapid HIV testing in these 
populations.

I. Funding Opportunity Description

    Authority: This program is authorized under the Public Health 
Service Act sections 301, 311, and 317 (42 U.S.C. 241, 243 and 
247(b)), as amended.

    Purpose: The purpose of the program is to: (PART 1) introduce rapid 
HIV testing programs to serve attendees of HBCUs and Hispanic Serving 
Institutions (HSIs); (PART 2) develop and evaluate new models for 
providing rapid and conventional HIV testing into clinical venues that 
have not offered routine HIV screening in the past in high risk 
communities ; and (PART 3) introduce rapid HIV testing in clinical

[[Page 35036]]

and nonclinical settings that serve three specific populations 
disproportionately affected by HIV: Native Americans, migrant worker 
populations, and pre-or post-operative transgendered persons. 
Organizations may apply for one or more parts of this announcement. 
This program addresses the AHP goals of CDC's initiative, Advancing HIV 
Prevention: New Strategies for a Changing Epidemic, aimed at reducing 
barriers to early diagnosis of HIV infection and increasing access to 
quality medical care, treatment, and ongoing prevention services for 
those diagnosed with HIV. This program addresses the ``Healthy People 
2010'' focus area of identifying new HIV infections.
    Measurable outcomes of the program will be in alignment with the 
following performance goal for the National Center for HIV/STD and TB 
Prevention (NCHSTP): Strengthen the capacity nationwide to monitor the 
epidemic, develop and implement effective HIV prevention interventions 
and evaluate prevention programs. In addition, this program addresses 
the Division of HIV/AIDS Prevention priorities: Develop new methods for 
diagnosing HIV infection, and institute integrated surveillance with 
emphasis on incidence, behavioral surveillance, and evaluation.
    Activities: Activities for awardees under any part of this program 
are as follows:
     Develop a program plan in collaboration with CDC and other 
participating sites.
     Conduct routine HIV testing (using HIV rapid tests or 
conventional HIV screening tests depending on venue) in the funded 
facilities and for the funded populations. For these facilities, offer 
HIV testing to all patients between 18 and 49 years of age during the 
project year.
     Throughout the project, keep detailed records of barriers 
and successes in developing an HIV testing program within the 
population targeted or venue, to serve as guidance on how to create and 
implement similar programs in other venues.
     Collect and maintain a database of information linked to 
screening and confirmatory tests, including data routinely collected on 
patient characteristics, testing site, HIV test(s) performed, reasons 
for refusal of testing, modes of follow up and results of follow up, 
disposition of clients with confirmed positive tests with respect to 
services received, and other information deemed necessary by CDC and 
grantees. For persons with confirmed positive HIV tests, additional 
information will be collected at the time of receipt of confirmatory 
tests and at some point after (e.g., six months) to determine potential 
and actual barriers to access to care and other qualitative information 
deemed important by funded organizations, the CDC and grantees.
     Develop a plan for evaluation of the project in 
conjunction with CDC, and conduct evaluations of the project near the 
end of the project period. Evaluations may include process outcomes 
such as numbers of clients tested and seropositivity rates, as well as 
comparisons to historical data on HIV testing in the facility or a 
description of uptake of testing by the populations served.
     Participate in periodic conference calls, site visits and 
grantee meetings with other funded sites and the CDC.
     Disseminate findings jointly with CDC and other 
participating sites.
    In addition to the above activities, grantees for Part 1 may 
propose the following:
     During the first 6 months of the project period, develop 
and conduct a focus program of formative research to determine factors 
or services which might contribute to increasing acceptance of testing 
among students attending HBCUs.
    In a cooperative agreement, CDC staff is substantially involved in 
the program activities, above and beyond routine grant monitoring. CDC 
Activities for this program are as follows:
     Assist in the development and review of required program 
plans, protocols, evaluation plans, and data collection tools.
     Provide guidelines for HIV counseling and testing and for 
rapid HIV testing.
     Provide guidance and assistance in the development of data 
management systems and procedures.
     Facilitate conference calls, grantee meetings, and site 
visits.
     Assist in the analysis and dissemination of single-site 
and multi-site data.

II. Award Information

    Type of Award: Cooperative Agreement. CDC involvement in this 
program is listed in the Activities Section above.
    Fiscal Year Funds: 2004.
    Approximate Total Funding: $ 2,480,020.
    Approximate Number of Awards:
    Part 1: Two to three awards for the development of rapid HIV 
testing programs for attendees of HBCUs.
    Part 2: Up to four awards for routine HIV testing in primary care 
clinics, community health centers, managed care organizations and 
alternative health clinics.
    Part 3: Four to six awards for rapid HIV testing in 
disproportionately affected populations.
    Approximate Average Award:
    Part 1: Historically Black Colleges and Universities: $250,000.
    Part 2: Primary care clinics and alternative health clinics: 
$250,000.
    Part 3: Native American, migrant farm workers, and pre- or post-
operative transgendered persons: $250,000.
    Floor of Award Range: None.
    Ceiling Award Range: None.
    Anticipated Award Date: September 1, 2004.
    Budget Period Length: 12 months.
    Project Period Length: 12 months.

III. Eligibility Information

III.1. Eligible Applicants

    Part 1. Applications may be submitted by:

 Historically Black Colleges and Universities
 Community-based organizations serving or collaborating with 
HBCUs
    Part 2. Applications may be submitted by public and non-profit 
organizations, such as:

 Community-based organizations
 Primary care clinics, either free-standing or in affiliation 
with hospitals
 Community Health Centers
 Managed care organizations
 Private non-profit organizations

    Part 3. Applications may be submitted by:

 Federally recognized Indian tribal governments
 Indian tribes
 Indian tribal organizations
 Community based organizations

III.2. Cost Sharing or Matching

    Matching funds are not required for this program.

III.3. Other

    CDC will accept and review applications with budgets greater than 
the ceiling of the award range.
    If your application is incomplete or non-responsive to the 
requirements listed in this section, it will not be entered into the 
review process. You will be notified that your application did not meet 
submission requirements.
    Part 1: For HBCUs, applicants must be colleges and universities 
with at least 50% Black enrollment and having a total student 
enrollment of at least 5,000 full and part time students. HBCUs who do 
not meet the minimum enrollment criteria may submit applications with 
strategies to include 2 or more HBCUs

[[Page 35037]]

located in the same geographic area in order to meet minimum enrollment 
requirements. In this latter case, one HBCU should take the lead on 
developing the proposal for submission.
    This announcement is not intended to provide funds to support 
direct instruction or curriculum implementation and training, nor are 
they intended to solely provide resources for HIV counseling and 
testing in the student health center, although this may be part of a 
larger strategy for providing HIV counseling and testing to this 
population.
    For community based organizations who apply for Part 1, a letter of 
collaboration or support from an HBCU or HBCUs serving a total 
enrollment of at least 5,000 full or part time students must be 
included.
    Part 2: Preference will also be given to programs that propose 
routine screening rather than targeted HIV testing or HIV testing based 
on risk assessment. Preference will be given to programs that propose 
to implement HIV testing with existing clinical staff. Additional non-
clinical staff, for example for data collection or entry, may be 
proposed.
    Health care settings that already routinely offer HIV testing to 
all patients (e.g., sexually transmitted disease clinics) will not be 
considered. Primary care clinics affiliated with hospitals and managed 
care organizations are encouraged to apply.
    Alternative health care facilities must be able to document at 
least 3,000 patient visits per year, be staffed by two or more 
clinicians, and demonstrate that the facility serves high risk 
populations. Alternatively, a high HIV prevalence in the population 
served by the facility may be demonstrated by satisfying at least one 
of the criteria listed below.
    High HIV prevalence may be demonstrated by: (1) HIV prevalence data 
demonstrating prevalence of at least one percent in the population 
served by the facility; (2) HIV or AIDS diagnosis rate of at least one 
per thousand hospital discharges for health centers and clinics in the 
referral network for the hospital; (3) eligibility for Title II Ryan 
White Care Act funds; (4) comparison data demonstrating that the 
facility's patient population is similar to that of other medical care 
facilities with HIV/AIDS prevalence rates of at least one percent; (5) 
demonstration that the facility serves a high risk population.
    Part 3: Preference will be given to programs that propose routine 
screening rather than targeted HIV testing or HIV testing based on risk 
assessment. Preference will be given to programs that propose to 
implement HIV testing with existing clinical staff. Additional non-
clinical staff, for example for data collection or entry, may be 
proposed.
    For populations of Native Americans and migrant farm workers, 
outreach programs must be able to identify and test a minimum of 1000 
persons per year in outreach or clinical settings from the population 
of interest, preferably using the HIV rapid test. For pre-or post-
operative transgendered persons, outreach programs must be able to 
identify and test a minimum of 250 persons per year in outreach or 
clinical settings from this population. Primary care or specialty 
medical clinics that primarily serve these populations are encouraged 
to apply.
    CBOs and Indian tribes are encouraged to apply and should 
collaborate with their respective Health Departments and other 
appropriate organizations. If non-tribal organizations apply to work 
with American Indian populations, they must show a past record of 
collaboration with these populations.
    In addition, organizations should coordinate program activities 
with health department HIV/AIDS programs, and comply with all health 
department requirements regarding HIV counseling, testing and referral; 
HIV/AIDS reporting; partner counseling and referral services; and other 
program activities. Funded organizations should collect and report all 
information required by the health department related to services 
provided under this announcement.


    Note: Title 2 of the United States Code 1611 states that an 
organization described in section 501(c)(4) of the Internal Revenue 
Code that engages in lobbying activities is not eligible to receive 
Federal funds constituting an award, grant, or loan.

IV. Application and Submission Information

IV.1. Address To Request Application Package

    To apply for this funding opportunity, use application form PHS 
5161. Application forms and instructions are available on the CDC Web 
site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm. If you do not have access to the Internet, or if you have 
difficulty accessing the forms online, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to 
you.

IV.2. Content and Form of Submission

    Application: You must submit a project narrative with your 
application forms. The narrative must be submitted in the following 
format:
     Maximum number of pages: [20] If your narrative exceeds 
the page limit, only the first pages which are within the page limit 
will be reviewed

     Font size: 12 point unreduced
     Double spaced
     Paper size: 8.5 by 11 inches
     Page margin size: One inch
     Printed only on one side of page
     Held together only by rubber bands or metal clips; not 
bound in any other way.

    Your narrative should address activities to be conducted over the 
entire project period, and must include the following items in the 
order listed: Understanding of the Need; Objectives; Methods; Timeline; 
Evaluation Plan; Staff; Budget and Justification.
    Additional information may be included in the application 
appendices. The appendices will not be counted toward the narrative 
page limit. This additional information includes: resumes of key staff; 
staffing plans; training agreements and other memoranda of 
understanding to assure that linkages with other appropriate 
organizations are in place; descriptive information regarding the 
applicant's organization or affiliated programs, i.e., pamphlets, 
brochures, other documents; appropriate reference materials to support 
applicant's application, i.e., publications concerning risk within the 
communities served by the organization; references from other funding 
organizations that have previously funded the applicant for HIV 
prevention projects.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. Your DUNS number must be entered 
on line 11 of the face page of the PHS 398 application form. The DUNS 
number is a nine-digit identification number, which uniquely identifies 
business entities. Obtaining a DUNS number is easy and there is no 
charge. To obtain a DUNS number, access http://www.dunandbradstreet.com 
or call 1-866-705-5711. For more information, see the CDC Web site at: 
http://www.cdc.gov/od/pgo/funding/pubcommt.htm.
    If your application form does not have a DUNS number field, please 
write your DUNS number at the top of the first page of your 
application, and/or include

[[Page 35038]]

your DUNS number in your application cover letter.
    Additional requirements that may require you to submit additional 
documentation with your application are listed in section ``VI.2. 
Administrative and National Policy Requirements.''

IV.3. Submission Dates and Times

    Application Deadline Date: July 23, 2004.
    Explanation of Deadlines: Applications must be received in the CDC 
Procurement and Grants Office by 4 p.m. eastern time on the deadline 
date. If you send your application by the United States Postal Service 
or commercial delivery service, you must ensure that the carrier will 
be able to guarantee delivery of the application by the closing date 
and time. If CDC receives your application after closing due to: (1) 
Carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, you will be given the opportunity to 
submit documentation of the carriers guarantee. If the documentation 
verifies a carrier problem, CDC will consider the application as having 
been received by the deadline.
    This announcement is the definitive guide on application submission 
address and deadline. It supersedes information provided in the 
application instructions. If your application does not meet the 
deadline above, it will not be eligible for review, and will be 
discarded. You will be notified that your application did not meet the 
submission requirements.
    CDC will not notify you upon receipt of your application. If you 
have a question about the receipt of your application, first contact 
your courier. If you still have a question, contact the PGO-TIM staff 
at: 770-488-2700. Before calling, please wait two to three days after 
the application deadline. This will allow time for applications to be 
processed and logged.

IV.4. Intergovernmental Review of Applications

    Your application is subject to Intergovernmental Review of Federal 
Programs, as governed by Executive Order (EO) 12372. This order sets up 
a system for state and local governmental review of proposed federal 
assistance applications. You should contact your state single point of 
contact (SPOC) as early as possible to alert the SPOC to prospective 
applications, and to receive instructions on your state's process. 
Click on the following link to get the current SPOC list: http://www.whitehouse.gov/omb/grants/spoc.html.

IV.5. Funding Restrictions

    Restrictions, which must be taken into account while writing your 
budget, are as follows:
     Awards will not allow reimbursement of pre-award costs.
    If you are requesting indirect costs in your budget, you must 
include a copy of your indirect cost rate agreement. If your indirect 
cost rate is a provisional rate, the agreement should be less than 12 
months of age.
    Guidance for completing your budget can be found on the CDC Web 
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm.

IV.6. Other Submission Requirements

    Application Submission Address: Submit the original and two hard 
copies of your application by mail or express delivery service to: 
Technical Information Management-PA 04158, CDC Procurement and 
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341.
    Applications may not be submitted electronically at this time.

V. Application Review Information

V.1. Criteria

    You are required to provide measures of effectiveness that will 
demonstrate the accomplishment of the various identified objectives of 
the cooperative agreement. Measures of effectiveness must relate to the 
performance goals stated in the ``Purpose'' section of this 
announcement. Measures must be objective and quantitative, and must 
measure the intended outcome. These measures of effectiveness must be 
submitted with the application and will be an element of evaluation.
    Your application will be evaluated against the following criteria, 
whether you are applying to Part 1, Part 2 or Part 3:
    1. Methods (40 points): Are the proposed methods feasible? Will 
they accomplish program goals? Can the proposed methods for offering 
routine testing be sustainable by existing staff after the project 
period (especially important for Part 2)? Does the applicant describe a 
plan for routinely recommending voluntary HIV testing in the identified 
setting or to the identified populations; the process for promoting and 
offering rapid or conventional HIV tests; the setting in which HIV 
counseling, testing, and referral services will be provided; clearly 
defined mechanisms for referral into care, treatment, and prevention 
services for patients testing positive for HIV; training for project 
staff; a reasoned approach of how to contact clients when necessary to 
ensure receipt of confirmatory test results for all positives; and a 
system for reporting HIV-positive test results to the health 
department, where required? Is a time line with realistic and 
measurable milestones for major project activities provided?
    2. Capacity (20 points): Does the applicant have the appropriate 
facilities and staff to conduct this program? Is adequate and objective 
information provided to demonstrate the availability of sufficient 
numbers of clients and sufficient prevalence of HIV risk behaviors or 
rates of seroprevalence in the populations being targeted? Is the 
project director well qualified, by education and experience, to lead 
the project team, hire and train appropriate staff, and provide 
programmatic and scientific oversight? Has the applicant established 
relationships to assure oversight, supervision, and regulatory 
compliance for rapid HIV testing?
    3. Objectives (20 points): Are the objectives reasonable, time-
phased and measurable? Does the applicant provide reasonable methods to 
evaluate their progress toward the timely accomplishment of objectives?
    4. Evaluation (20 points): Are evaluation methods described? Are 
the outcome measures clearly related to the objectives? Are the types 
of process and outcome data proposed in the evaluation plan readily 
collected? To determine the effectiveness of the program, does the 
applicant have access to counseling and testing data for their area to 
serve as a comparison group; or does the applicant intend to use data 
from existing counseling and testing programs within the proposed 
venue(s) as a comparison group; or does the applicant intend to compare 
different methods of delivering counseling and testing programs to a 
particular population or in a particular venue?
    5. Budget (not scored): Is the budget reasonable for the proposed 
activities? Does the budget allow for sufficient time--approximately 
three to six months--for the development of the program plan and review 
by CDC and other entities?

V.2. Review and Selection Process

    Applications will be reviewed for completeness by the Procurement 
and Grants Office (PGO) staff and for responsiveness by the National 
Center for HIV/STD/TB Prevention, Division of HIV/AIDS Prevention. 
Incomplete

[[Page 35039]]

applications and applications that are non-responsive to the 
eligibility criteria will not advance through the review process. 
Applicants will be notified that their application did not meet 
submission requirements.
    An objective review panel will evaluate complete and responsive 
applications according to the criteria listed in the ``V.1. Criteria'' 
section above.
    Applicants may apply for any or all of the target populations or 
settings. A separate application should be submitted for each setting 
or population proposed. Applications from each target population will 
be evaluated independently by the objective review panel and will be 
ranked against applications from the same target population according 
to the Evaluation Criteria.
    In addition, the following factors may affect the funding decision:
    Preference will be given to applicants who propose settings which 
will provide a diverse ethnic, racial or risk population with regard to 
the overall selection of venues participating in the demonstration 
projects.

V.3. Anticipated Announcement and Award Dates

    Awards will be issued on or about September 1, 2004.

VI. Award Administration Information

VI.1. Award Notices

    Successful applicants will receive a Notice of Grant Award (NGA) 
from the CDC Procurement and Grants Office. The NGA shall be the only 
binding, authorizing document between the recipient and CDC. The NGA 
will be signed by an authorized Grants Management Officer, and mailed 
to the recipient fiscal officer identified in the application.
    Unsuccessful applicants will receive notification of the results of 
the application review by mail.

VI.2. Administrative and National Policy Requirements

45 CFR Part 74 and Part 92
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    The following additional requirements apply to this project:

 AR-2 Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
 AR-4 HIV/AIDS Confidentiality Provisions
 AR-5 HIV Program Review Panel Requirements
 AR-6 Patient Care
 AR-7 Executive Order 12372
 AR-8 Public Health System Reporting Requirements
 AR-10 Smoke-Free Workplace Requirements
 AR-11 Healthy People 2010
 AR-12 Lobbying Restrictions
 AR-14 Accounting System Requirements
 AR-15 Proof of Non-Profit Status
 AR-21 Small, Minority, and Women-Owned Business
     AR-24 Health Insurance Portability and Accountability Act 
Requirements

    Additional information on these requirements can be found on the 
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm.

VI.3. Reporting Requirements

    You must provide CDC with an original, plus two hard copies of the 
following reports:
    1. Interim progress report, no less than 90 days before the end of 
the first 12-month budget period. The progress report will serve as 
your non-competing continuation application, and must contain the 
following elements:

a. Current Budget Period Activities Objectives
b. Current Budget Period Financial Progress
c. New Budget Period Program Proposed Activity Objectives
d. Budget
e. Additional Requested Information
f. Measures of Effectiveness
    2. Financial status report, no more than 90 days after the end of 
the budget period.
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    These reports must be mailed to the Grants Management Specialist 
listed in the ``Agency Contacts'' section of this announcement.

VII. Agency Contacts

    For general questions about this announcement, contact: Technical 
Information Management Section, CDC Procurement and Grants Office, 2920 
Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-2700.
    For program technical assistance, contact: Scott Kellerman, MD, 
MPH, Extramural Project Officer, 1600 Clifton Road, MS E-46, Atlanta, 
Georgia 30333, Telephone: 404-639-4484, E-mail: [email protected].
    For financial, grants management, or budget assistance, contact: 
Betty Vannoy, Contract Specialist, CDC Procurement and Grants Office, 
2920 Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-2897, E-
mail: [email protected].

    Dated: June 16, 2004.
William Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-14174 Filed 6-22-04; 8:45 am]
BILLING CODE 4163-18-P